Ticker
AKBACompany Name
AKEBIA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Inventory | Current Liabilities | Quick Ratio |
---|---|---|---|---|
6/30/2025 | $ 234.66M | $ 16.71M | $ 118.72M | 1.84 |
3/31/2025 | $ 203.78M | $ 19.73M | $ 91.23M | 2.02 |
12/31/2024 | $ 113.83M | $ 16.24M | $ 80.91M | 1.21 |
9/30/2024 | $ 100.12M | $ 20.49M | $ 65.71M | 1.21 |
6/30/2024 | $ 112.1M | $ 23.87M | $ 107.3M | 0.82 |
3/31/2024 | $ 112.94M | $ 25.53M | $ 66.49M | 1.31 |
12/31/2023 | $ 118.15M | $ 15.69M | $ 99.87M | 1.03 |
9/30/2023 | $ 109.6M | $ 18.44M | $ 79.7M | 1.14 |
6/30/2023 | $ 118.45M | $ 20.91M | $ 92.18M | 1.06 |
3/31/2023 | $ 120.72M | $ 20.6M | $ 82.94M | 1.21 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(AssetsC - Inventory) / LiabilitesC
(=) Quick Ratio
Quick Ratio for AKEBIA THERAPEUTICS INC is calculated as follows: (AssetsC [ $ 391M ] - Inventory [ $ 88.24M ]) / LiabilitesC [ $ 181.46M ]
(=) Quick Ratio [ 1.67 ]
Minimum
Jun 30, 2024
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.12K |
---|---|
min | -0.73 |
max | 5.45 |
average | 1.55 |
median | 1.23 |
std | 1.17 |